.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Johnson and Johnson
Dow
Deloitte
Farmers Insurance
Colorcon
Express Scripts
Mallinckrodt
McKesson
Federal Trade Commission

Generated: September 26, 2017

DrugPatentWatch Database Preview

ALOMIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Alomide, and what generic Alomide alternatives are available?

Alomide is a drug marketed by Novartis Pharms Corp and is included in one NDA.

The generic ingredient in ALOMIDE is lodoxamide tromethamine. One supplier is listed for this compound. Additional details are available on the lodoxamide tromethamine profile page.

Summary for Tradename: ALOMIDE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list35
Drug Prices:see details
DailyMed Link:ALOMIDE at DailyMed

Pharmacology for Tradename: ALOMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
ALOMIDE
lodoxamide tromethamine
SOLUTION/DROPS;OPHTHALMIC020191-001Sep 23, 1993RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ALOMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
ALOMIDE
lodoxamide tromethamine
SOLUTION/DROPS;OPHTHALMIC020191-001Sep 23, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Daiichi Sankyo
Teva
Chubb
Fuji
Johnson and Johnson
Boehringer Ingelheim
US Department of Justice
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot